Saint-Gobain Acquires Three Construction Chemical Firms

Saint-Gobain has strengthened its construction chemicals business with the acquisition of three companies: Interstar Materials in North America, Isoltech in Italy, and Soquimic in Peru.

Saint-Gobain logo on a building
© Sophie Animes - stock.adobe.com

Interstar, operating from facilities in Canada and the US, supplies high-performance pigments for concrete, expanding Saint-Gobain’s decorative and architectural concrete solutions portfolio.

Based in northern Italy, Isoltech develops additives for cellular concrete, a lightweight material valued for its insulation, fire resistance, and recyclability, supporting sustainable building practices.

Soquimic, with two plants near Lima and Arequipa, enhances Saint-Gobain’s reach in the high-growth Peruvian market while complementing its existing local operations.

Collectively, these acquisitions will generate around €25 million in additional annual revenue and will benefit from Chryso’s expertise in innovation, R&D, and low-carbon solutions. They align with Saint-Gobain’s “Grow & Impact” strategy, reinforcing its global leadership and accelerating the development of advanced, sustainable construction products tailored to evolving market needs.

Company

Logo:

Saint-Gobain

Tour Saint-Gobain - 12 place de l’Iris
92096 La Défense Cedex
France

Company contact







Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.